To annotate previously unreported lincRNAs associated with breast cancer, we performed paired-end whole transcriptome sequencing (RNA-Seq) using RNA for 33 samples from 11 groups encompassing tissues representing five breast cancer subtypes [luminal A, luminal B (HER2+), luminal B (HER2−), HER2, and triple negative], adjacent noncancerous breast tissues, and normal breast tissues according to St Gallen International Expert Consensus8 (Additional file 1: Table S2). This evidence concerns the gene ERBB2 and breast carcinoma.